Carolina Méndez-Blanco

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 9

Top Venues

Cancers

Clinical pharmacology and therapeutics

Experimental & molecular medicine

Nutrients

Institute of Biomedicine (IBIOMED)-University of León

University of León (BSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Institute of Biomedicine (IBIOMED)-University of León

Spain

PhD Student

Education History

University of León

Spain

BSC

Publications

Tania Payo-Serafín, Carolina Méndez-Blanco, Paula Fernández-Palanca, Jennifer Martínez-Geijo, María Reviejo, Juan José Ortiz-de-Urbina, Javier Gonzalez-Gallego, Jose J G Marin, José Luis Mauriz, Beatriz San-Miguel
Risk versus Benefit of Tyrosine Kinase Inhibitors for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Clinical pharmacology and therapeutics 116 (2) (2024)
Tania Payo-Serafín, Carolina Méndez-Blanco, Paula Fernández-Palanca, Jennifer Martínez-Geijo, María Reviejo, Juan José Ortiz-de-Urbina, Javier Gonzalez-Gallego, Jose J G Marin, José Luis Mauriz, Beatriz San-Miguel
Risk versus Benefit of Tyrosine Kinase Inhibitors for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Clinical pharmacology and therapeutics (2024)
Carolina Méndez-Blanco, Flavia Fondevila, Paula Fernández-Palanca, Andrés García-Palomo, Jos van Pelt, Chris Verslype, Javier Gonzalez-Gallego, José Luis Mauriz
Correction: Méndez-Blanco et al. Stabilization of Hypoxia-Inducible Factors and BNIP3 Promoter Methylation Contribute to Acquired Sorafenib Resistance in Human Hepatocarcinoma Cells. Cancers 2019, 11 , 1984. Cancers 15 (23) (2023)
Paula Fernández-Palanca, Tania Payo-Serafín, Flavia Fondevila, Carolina Méndez-Blanco, Beatriz San-Miguel, Marta R Romero, María Jesús Tuñón, Jose J G Marin, Javier Gonzalez-Gallego, José Luis Mauriz
Neuropilin-1 as a Potential Biomarker of Prognosis and Invasive-Related Parameters in Liver and Colorectal Cancer: A Systematic Review and Meta-Analysis of Human Studies. Cancers 14 (14) (2022)
Flavia Fondevila, Paula Fernández-Palanca, Carolina Méndez-Blanco, Tania Payo-Serafín, Elisa Lozano, Jose J G Marin, Javier Gonzalez-Gallego, José Luis Mauriz
Association of FOXO3 Expression with Tumor Pathogenesis, Prognosis and Clinicopathological Features in Hepatocellular Carcinoma: A Systematic Review with Meta-Analysis. Cancers 13 (21) (2021)
Flavia Fondevila, Carolina Méndez-Blanco, Paula Fernández-Palanca, Tania Payo-Serafín, Jos van Pelt, Chris Verslype, Javier Gonzalez-Gallego, José Luis Mauriz
Autophagy-Related Chemoprotection against Sorafenib in Human Hepatocarcinoma: Role of FOXO3 Upregulation and Modulation by Regorafenib. International journal of molecular sciences 22 (21) (2021)
Paula Fernández-Palanca, Flavia Fondevila, Carolina Méndez-Blanco, María Jesús Tuñón, Javier Gonzalez-Gallego, José Luis Mauriz
Antitumor Effects of Quercetin in Hepatocarcinoma In Vitro and In Vivo Models: A Systematic Review. Nutrients 11 (12) (2019)
Flavia Fondevila, Carolina Méndez-Blanco, Paula Fernández-Palanca, Javier Gonzalez-Gallego, José Luis Mauriz
Anti-tumoral activity of single and combined regorafenib treatments in preclinical models of liver and gastrointestinal cancers. Experimental & molecular medicine 51 (9) (2019)
Carolina Méndez-Blanco, Flavia Fondevila, Andrés García-Palomo, Javier Gonzalez-Gallego, José Luis Mauriz
Sorafenib resistance in hepatocarcinoma: role of hypoxia-inducible factors. Experimental & molecular medicine 50 (10) (2018)

Carolina Méndez-Blanco.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Carolina Méndez-Blanco